Aktis Oncology, Inc. (AKTS)
Aktis Oncology will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Aktis Oncology Revenue
Aktis Oncology had revenue of $5.56M in the twelve months ending September 30, 2025. In the year 2024, Aktis Oncology had annual revenue of $1.49M.
Revenue (ttm)
$5.56M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$73,158
Employees
76
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.49M | - | - |
| Dec 31, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAKTS News
- 5 days ago - Aktis Oncology files for US IPO as biotech listings rebound - Reuters
- 5 days ago - Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO - Renaissance Capital
- 5 days ago - Aktis Oncology IPO Registration Document (S-1) - SEC